Comprehensive information on 10,000+ stocks and funds, including all the companies in the S&P 500 index. See stock prices, news, social sentiment, financials, forecasts, business, management and more.
US index futures were little changed early on September 25, 2026 as investors weighed higher bond yields and elevated oil prices; the recent bond sell-off has kept pressure on equities even as indexes hover not far from record levels. (finance.yahoo.com)
Markets remain focused on the Federal Reserve’s policy path after a 25 bp rate hike last week and stronger-than-expected business activity data, which have raised odds of another hike and kept Treasury yields at multi‑year highs. (fidelity.com)
Energy and macro headlines (oil above recent ranges, Iran-related geopolitical risk at the UN, and concerns about global growth) continue to drive sector rotations, with cyclicals and rate‑sensitive growth stocks reacting most to moves in yields and crude. (apnews.com)
| Date | Ticker | Company Name | Offer Amount |
|---|---|---|---|
| Oct 9 | RTSN | Retension Pharmaceuticals, Inc. | $45,000,000 |
| Oct 9 | TRXB | TRex Bio, Inc. | $116,666,676 |
| Date | Ticker | Company Name | Offer Amount |
|---|---|---|---|
| Oct 14 | FLSC | Frazier Life Sciences Acquisition Corp. II | $75,000,000 |
| Oct 15 | SCQCU | SPACCircle Acquisition Corp. | $172,500,000 |
| Oct 15 | IAM | Iambic Therapeutics, Inc. | $183,281,250 |
| Oct 16 | CTY | CITY THERAPEUTICS, INC. | $212,430,545 |